Hikma Pharmaceuticals PLCHIK:LSE

1,496
7.00 / 0.47 %
391.36k
63.35%
0.663
Close in GBXToday's changeShares traded1 year changeBeta
As of Apr 17 2014 16:35 BST.Data delayed by at least 15 minutes.

Summary

On Thursday, Hikma Pharmaceuticals PLC (HIK:LSE) closed at 1,496, 11.95 % below its 52-week high of 1,699, set on Mar 20, 2014.

52-week range
Today
893.45
Apr 17 2013
1,699
Mar 20 2014
Open1,503
Day high1,522
Day low1,496
Bid1,475
Offer1,650
Previous close1,503
Average volume315.00k
Shares outstanding198.16m
Free float130.54m
P/E (TTM)23.44
Market cap2.97bn GBP
EPS (TTM)0.6384 GBP
Annual div (TTM)12.30 GBX
Annual div yield (TTM)0.82%
Div ex-dateSep 04 2013
Div pay-dateOct 07 2013
Next div ex-dateApr 23 2014
Next div pay-dateMay 22 2014
Last IC View
The last IC recommendation on Hikma Pharmaceuticals PLC shares was Sell at 1,485 on 12 Mar 2014
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Hikma Pharmaceuticals PLC-4.04 %-8.89 %+34.29 %+63.35 %+284.55 %
FTSE 100 Index-0.25 %+0.87 %+0.75 %+6.10 %+61.88 %
GB/HEALTH CARE+0.33 %-5.80 %+6.60 %+4.98 %--
GB/PHARMACEUTICALS+0.46 %-5.66 %+6.46 %+4.30 %--
As of Apr 17 2014 16:35 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.